Cliniko-experimental research of trimetazidine efficiency at the myocardium ischemia
| Autor: | O. V Romashchenko |
|---|---|
| Jazyk: | English<br />Russian |
| Rok vydání: | 2013 |
| Předmět: | |
| Zdroj: | КардиоСоматика, Vol 4, Iss 2, Pp 43-47 (2013) |
| Druh dokumentu: | article |
| ISSN: | 2221-7185 2658-5707 |
| Popis: | The randomized controllable clinical research of Trimetazidine (Preductal MB) efficiency was spent at 95 patients with a stable angina pectoris. There were revealed the authentic increase in 2 times of treatment’s clinical efficiency in patients, who in addition to basic therapy appointed Trimetazidine for the account of more expressed antianginal effect and increase of physical working capacity. Additional appointment of Trimetazidine at a myocardium ischemia promoted the reduction of energy deficiency and tissue hypoxia. Last position has proved to be true according to experimental data: at rats males of line Vistar at experimental IHD the introduction of Trimetazidine led to increase of recycling of carbohydrates with the power purposes in a cardiac muscle that was accompanied by signs of stabilisation of cardiomyocytes’ membranes and reduction of degree of tissue hypoxia. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|